Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ANKRD33BP7 (Ankyrin repeat domain 33B pseudogene 7) is a segment of DNA that resembles the ANKRD33B gene but does not encode a functional protein. Instead, as a pseudogene, ANKRD33BP7 contains sequence similarity to the active gene family but is non-functional due to accumulated mutations or lack of regulatory elements. The active gene in this family, ANKRD33B, encodes a protein with ankyrin repeat domains: these domains frequently mediate protein-protein interactions involved in diverse cellular processes[1][3]. However, the pseudogene variant does not contribute to these processes or act as a molecular target in current biomedical sciences[1]. Notes on nomenclature: - ANKRD33B is a protein-coding gene with potential disease relevance, but ANKRD33BP7 is specifically a pseudogene, so the canonical name should explicitly include "pseudogene 7." - If you intended to refer to the active protein-coding gene, that would be “Ankyrin repeat domain 33B (ANKRD33B),” not “ANKRD33BP7.”[1][3]
Not applicable; pseudogenes do not encode functional proteins, so do not serve as a mechanism-based target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ankyrin repeat domain 33B pseudogene 7 (ANKRD33BP7).